Login / Signup
How to manage prolonged immune effector cell-associated hematotoxicity (ICAHT) related to BCMA-directed myeloma therapy.
James A Davis
Mary McGann
Jessica Marini
Hamza Hashmi
Published in:
Expert review of anticancer therapy (2024)
Keyphrases
</>
cell therapy
single cell
regulatory t cells
dendritic cells
multiple myeloma
newly diagnosed
stem cells
drug induced